Masimo Announced The Findings Of A Study Published Evaluating The Ability Of Masimo Sedline Brain Function Monitoring To Assess The Sedation Levels Of Patients Undergoing Drug-Induced Sleep Endoscopy With Dexmedetomidine
Portfolio Pulse from Benzinga Newsdesk
Masimo has announced the findings of a study evaluating the ability of its Sedline brain function monitoring to assess the sedation levels of patients undergoing drug-induced sleep endoscopy with Dexmedetomidine. The study found that Masimo PSi, a processed EEG parameter, better captured changes in brain state compared to other assessment methods.
August 07, 2023 | 12:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The study's positive findings about Masimo's Sedline brain function monitoring could potentially boost the company's reputation and sales, leading to a positive impact on its stock.
The study's positive findings about Masimo's Sedline brain function monitoring could enhance the product's reputation and increase its sales. This could lead to increased revenues for Masimo, which could positively impact its stock price. However, the extent of the impact will depend on how significant the Sedline product is to Masimo's overall business.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100